BrightSpring Health Services, Inc. BTSG R2K

Healthcare · Health Information Services · United States

https://www.brightspringhealth.com

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Market & Price

Market Cap

$11.96B

Current Price

$61.68

High / Low (52W)

$61.68 / $19.36

Beta

1.72

Valuation

Stock P/E

80.10

Industry PE

23.65

Forward P/E

29.19

PEG Ratio

Book Value

$9.66

Price to Book

6.39

P/S

0.88

EV/EBITDA

26.23

Dividend Yield

Profitability & Returns

ROCE

6.47%

ROE

9.23%

ROA

4.07%

Profit Margin

2.27%

Op Margin

3.36%

EPS (Latest Qtr)

$0.67

EPS (TTM)

$0.77

Balance Sheet & Liquidity

Debt/Equity

1.36

Quick Ratio

1.36

Current Ratio

1.74

Debt

$2.70B

Total Assets

$6.41B

Current Assets

$2.89B

Working Capital

$1.05B

Ownership

Promoter Holding

3.19%

Chg in Prom Hold

FII / Inst Holding

110.64%

Chg in FII Hold

-0.00%

Financial Snapshot

Enterprise Value

$14.51B

Total Revenue (TTM)

$13.65B

EBITDA

$552.97M

Free Cash Flow

$1.01B

Operating Cash Flow

$511.51M

Shares Outstanding

193.92M

Gross Margin

12.18%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

18.69%

Profit 5Y

151.23%

Revenue (YoY)

25.60%

Earnings (YoY)

359.80%

PROS

Compounding revenue at 18.7% over 5 years.
Profit CAGR of 151.2% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Trading at a high P/E of 80.1.
RSI at 76 suggests overbought conditions.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	BTSG BrightSpring Health Services, Inc. R2K	61.68	80.10	$11.96B	-	6.47%	9.23%	18.69%	151.23%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	2.03B	2.17B	2.26B	2.29B	2.44B	2.60B	-	2.88B	3.15B	3.33B	3.55B	3.61B
Cost of Revenue	-	-	-	-	-	-	-	2.54B	2.77B	2.94B	3.14B	3.13B
Gross Profit	334.71M	372.07M	358.30M	292.49M	312.18M	323.09M	-	338.37M	374.85M	392.01M	412.55M	482.22M
Operating Expenses	-	-	-	-	-	-	-	287.63M	326.30M	304.17M	304.44M	360.77M
Operating Income	51.55M	79.62M	-52.25M	-15.34M	38.65M	29.10M	-	50.74M	48.56M	87.84M	108.11M	121.45M
EBITDA	-	-	-	-	-	-	-	92.90M	90.40M	128.60M	147.64M	160.54M
Interest Expense	-	-	-	-	-	-	-	41.76M	38.78M	38.23M	38.53M	38.62M
Pretax Income	-	-	-	-	-	-	-	8.98M	9.78M	49.61M	69.58M	82.83M
Tax Provision	-	-	-	-	-	-	-	-240.00K	1.24M	12.12M	20.03M	8.55M
Net Income	-21.38M	3.99M	-130.67M	-45.75M	19.92M	-8.23M	-	29.54M	28.21M	55.84M	77.08M	148.77M
Diluted EPS	-0.18	0.03	-1.11	-0.26	0.10	-0.04	-	0.14	0.13	0.26	0.35	0.67

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	7.72B	7.69B	10.07B	12.91B
Cost of Revenue	-	6.37B	6.55B	8.81B	11.39B
Gross Profit	-	1.35B	1.14B	1.27B	1.52B
Operating Expenses	-	1.13B	1.08B	1.16B	1.22B
Operating Income	-	228.69M	58.12M	107.95M	295.25M
EBITDA	-	391.80M	260.46M	299.71M	459.53M
Interest Expense	-	233.58M	271.90M	190.55M	157.31M
Pretax Income	-	-45.75M	-213.77M	-95.32M	137.94M
Tax Provision	-	8.46M	-31.51M	-26.39M	33.15M
Net Income	-	-53.91M	-154.60M	-18.06M	190.67M
Diluted EPS	-	-0.31	-0.90	-0.09	0.87

Compounded Sales Growth

5 Years:	18.69%
1 Year:	25.60%

Compounded Profit Growth

5 Years:	151.23%
1 Year:	359.80%

Stock Price Performance

1 Year:	+159.05%
6 Months:	+70.29%
3 Months:	+48.88%
1 Month:	+28.10%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	5.44B	5.53B	5.93B	6.41B
Current Assets	-	1.34B	1.46B	1.89B	2.89B
Cash & Equivalents	-	13.63M	13.07M	60.95M	88.37M
Inventory	-	430.52M	402.78M	636.56M	815.18M
Receivables	-	775.84M	881.63M	902.78M	989.72M
Total Liabilities	-	4.66B	4.92B	4.27B	4.53B
Current Liabilities	-	932.51M	1.25B	1.43B	1.85B
Long Term Debt	-	3.36B	3.33B	2.56B	2.46B
Total Debt	-	3.68B	3.67B	2.79B	2.71B
Total Equity	774.82M	754.78M	584.74M	1.65B	1.88B
Shares Outstanding	-	171.19M	171.19M	174.25M	192.12M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-	-4.65M	210.78M	23.77M	490.17M
Investing Cash Flow	-	45.36M	-134.43M	-140.24M	-305.08M
Financing Cash Flow	-	-73.81M	-76.91M	164.65M	-157.87M
Capital Expenditure	-	-70.11M	-73.53M	-80.91M	-95.48M
Free Cash Flow	-	-74.77M	137.26M	-57.14M	394.69M
Net Change in Cash	-	-33.11M	-557.00K	48.18M	27.22M
Share Buybacks	-	-	650.00K	650.00K	43.17M

Ratios (Annual)

Figures in %.

Metric	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	17.5%	14.8%	12.6%	11.8%
Operating Margin %	-	3.0%	0.8%	1.1%	2.3%
Net Margin %	-	-0.7%	-2.0%	-0.2%	1.5%
ROE %	-	-7.1%	-26.4%	-1.1%	10.2%
ROCE %	-	5.1%	1.4%	2.4%	6.5%

Shareholding Pattern

Insiders

3.19%

Institutions

110.64%

Public Float

114.29%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Kohlberg Kravis Roberts & Co. L.P.	21.57%	41.82M	$2.58B
2	FMR, LLC	10.82%	20.98M	$1.29B
3	Blackrock Inc.	10.11%	19.60M	$1.21B
4	Invesco Ltd.	5.92%	11.48M	$708.22M
5	Price (T.Rowe) Associates Inc	5.50%	10.67M	$658.35M
6	Vanguard Portfolio Management LLC	4.14%	8.03M	$495.46M
7	T. Rowe Price Investment Management, Inc.	3.93%	7.63M	$470.57M
8	Vanguard Capital Management LLC	3.25%	6.30M	$388.32M
9	State Street Corporation	2.54%	4.93M	$304.33M
10	Manufacturers Life Insurance Co.	2.20%	4.26M	$262.71M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BTSG

No recent headlines available.

BTSG · Healthcare